I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| non-classical monocyte | 20 studies | 29% ± 10% | |
| classical monocyte | 18 studies | 25% ± 8% | |
| conventional dendritic cell | 17 studies | 29% ± 9% | |
| macrophage | 16 studies | 26% ± 9% | |
| monocyte | 12 studies | 31% ± 11% | |
| plasmacytoid dendritic cell | 7 studies | 26% ± 8% | |
| goblet cell | 6 studies | 26% ± 10% | |
| endothelial cell | 5 studies | 24% ± 6% | |
| myeloid cell | 5 studies | 31% ± 8% | |
| epithelial cell | 5 studies | 32% ± 12% | |
| alveolar macrophage | 5 studies | 26% ± 6% | |
| dendritic cell | 5 studies | 32% ± 15% | |
| T follicular helper cell | 4 studies | 41% ± 14% | |
| enterocyte | 4 studies | 20% ± 1% | |
| mucus secreting cell | 3 studies | 32% ± 6% | |
| luminal cell of prostate epithelium | 3 studies | 28% ± 8% | |
| GABAergic neuron | 3 studies | 23% ± 6% | |
| enteroendocrine cell | 3 studies | 24% ± 9% | |
| intestinal crypt stem cell | 3 studies | 19% ± 3% | |
| hepatocyte | 3 studies | 51% ± 22% | |
| connective tissue cell | 3 studies | 20% ± 4% | |
| CD4-positive, alpha-beta T cell | 3 studies | 24% ± 6% | |
| CD4-positive, alpha-beta cytotoxic T cell | 3 studies | 21% ± 1% | |
| CD8-positive, alpha-beta T cell | 3 studies | 19% ± 4% | |
| microglial cell | 3 studies | 20% ± 4% |
